Pharmacokinetic-pharmacodynamic assessment of the interrelationships between tesaglitazar exposure and renal function in patients with type 2 diabetes mellitus.
about
P2860
Pharmacokinetic-pharmacodynamic assessment of the interrelationships between tesaglitazar exposure and renal function in patients with type 2 diabetes mellitus.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pharmacokinetic-pharmacodynami ...... with type 2 diabetes mellitus.
@en
Pharmacokinetic-pharmacodynami ...... with type 2 diabetes mellitus.
@nl
type
label
Pharmacokinetic-pharmacodynami ...... with type 2 diabetes mellitus.
@en
Pharmacokinetic-pharmacodynami ...... with type 2 diabetes mellitus.
@nl
prefLabel
Pharmacokinetic-pharmacodynami ...... with type 2 diabetes mellitus.
@en
Pharmacokinetic-pharmacodynami ...... with type 2 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic-pharmacodynami ...... with type 2 diabetes mellitus.
@en
P2093
Bengt Hamrén
K Peter Ohman
Maria K Svensson
Mats O Karlsson
P2860
P304
P356
10.1177/0091270011416937
P577
2011-11-01T00:00:00Z